Organizing Committee Members - Dermatology & Melanoma 2023
CEO of Nanorx INC has a Ph.D. in Organic Chemistry from Oregon State University(1979) and M.S in Chemistry(1972) from I.I.T Mumbai, India. He has worked on drug discovery for over 25 years at Columbia University, Max-Planck Institute, Germany, Ciba-Geigy (now Novartis) and Boehringer Ingelheim. He has over 25 US and International patents and another 15 pending patent applications.
Palayakotai Raghavan(Research Area)
drug discovery, Metadichol and Skin diseases
Pur Medical Center
Shun io President, Plastic & Cosmetic Surgical Society of Macau Surgical Association Associate Doctor, Specialist in Plastic Cosmetic Surgery, Yi Kui Hospital (Macau) Medical Consultant, Paul Niehans Anti-Aging Center (Asia) Specialist in Cosmetic Surgery, Taiwan Specialist in Aesthetic Medicine, Taiwan Specialist in Anti-Aging Medicine, Taiwan Official Trainer of Derma Veil Aesthetics Training
Shun io(Research Area)
Plastic & Cosmetic Surgery, aesthetic medicine
Granada University School of Medicine
Germaine Escames has broad experience in the studies of the antioxidative role of melatonin and the identification of the mitochondria as the main target of melatonin, and its anti-inflammatory activity against the innate immune response, among others. From several years to date, her activity has been focused on the oncostatic activity of melatonin and the adverse effects of radio and chemotherapy. In addition, she studied the effects of melatonin on the skin. She has four international patents on melatonin: one is currently under a multicentric clinical trial (in 10 hospitals of Spain) for the prevention and healing of oral mucositis induced by radio and/or chemotherapy, and other two patents consist in a endovenous melatonin formulation for the treatment of sepsis. The fourth patent consists in a regenerative and anti-aging cream of melatonin for its topic application in the skin. A clinical trial with this cream to treat position ulcers is now being carried out in collaboration with other groups.
Germaine Escames(Research Area)
antioxidative role of melatonin and the identification of the mitochondria as the main target of melatonin
Kanazawa Medical University
Dr. Shigehiko Kawakami is a Professor Emeritus, Kanazawa Medical University, director of Kanazawa Medical University and Chairman of Board Directors, Japanese Society of Pressure Ulcers.He is graduated from Kanazawa University School of Medicine, Kanazawa, Japan and got a Medical doctor degree from Department of Plastic and Reconstructive Surgery, Kanazawa Medical University, Uchinada, Japan, he is specialised in Cranio-maxillo-facial surgery, Cleft lip & palate, Wound healing and Skin tumor.
Shigehiko Kawakami(Research Area)
Cranio-maxillo-facial surgery, Cleft lip & palate, Wound healing Skin tumor